BPA for relyvrio
Ended Awarded Last action
- Contract number
- 36E79723A0009
- Awardee
-
Amylyx Pharmaceuticals Inc. UEI Y5H6VQL1KHQ1
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- VA797P12Q0002 Solicitation number
- Last date to order 100% complete
- IDV ceiling
- $50,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The subject federal contract IDV is a Blanket Purchase Agreement (BPA) awarded by the National Acquisition Center, a division of the U.S. Department of Veterans Affairs (VA), to Amylyx Pharmaceuticals Inc. (Amylyx). The BPA, valued at $50,000, is for the procurement of RELYVRIO, an FDA-approved treatment for amyotrophic lateral sclerosis (ALS) developed by Amylyx.
As a self-certified small disadvantaged business, Amylyx has established several contract vehicles with the VA to facilitate the distribution of its pharmaceutical products to veterans. The BPA allows VA medical facilities nationwide to efficiently order RELYVRIO and other Amylyx products as needed. Amylyx also holds a Federal Supply Schedule (FSS) contract and another BPA with the VA, further demonstrating the company's commitment to providing ALS treatment to the veteran population through various contracting mechanisms. The BPA has a period of performance through June 27, 2023, with the option to extend, and does not utilize any set-aside designations. The place of performance is primarily Amylyx's headquarters in Cambridge, Massachusetts.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Legal Contract Cancellation | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79723A0009?
36E79723A0009 was awarded to Amylyx Pharmaceuticals Inc. by National Acquisition Center (Headquarters) on January 6, 2023.
How much is contract 36E79723A0009 worth?
36E79723A0009's own ceiling is $50,000.
Who can order from contract 36E79723A0009?
36E79723A0009 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 36E79723A0009 under another contract?
Yes. 36E79723A0009 is a blanket purchase agreement under 36F79723D010E, a federal supply schedule.
Was contract 36E79723A0009 competed?
The extent of competition for 36E79723A0009 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV